MENS Jyong Biotech: Book Valuation of Business

Public company logo of Jyong Biotech (MENS)

The historical price action of Jyong Biotech Ltd (MENS) demonstrates the current indicator -0.03. The business relies on Asian traditions of using herbal remedies for urology, which ensures a steady cash flow. However, its status as a low-liquidity micro-cap makes the company dependent on investments. Meanwhile, ownership of unique formulas guarantees the ability to produce low-cost mass-market medications following certification.

MENS - Jyong Bio Book Capitalization over the range 06/18/2025 - 10/29/2026
Mass-produced product of Jyong Biotech Limited

A conservative investor assesses the real value of assets, excluding market noise, by analyzing the difference between total liabilities and resource value. By examining the book value of equity chart for Jyong Biotech Ltd (MENS), one can determine the extent to which the funding of advanced laboratories and a staff of biologists is backed by actual capital, which serves as a warning against overpaying for unjustified price growth.

Competitor analysis for Jyong Biotech Ltd

HLN (Haleon Corp) - Accounting Capitalization|Kenvue Inc. (KVUE) - Company Book Value|VRNA - Book Valuation of Business|Company Book Value Ligand|Amneal Pharmaceuticals, Inc. - Net Asset Value|Book Capitalization PRGO|ALVO (Alvotech Biopharmaceuticals) - Accounting Value of Company|Book Capitalization LQDA (Liquidia Corporation)|Book Capitalization glpg.com GLPG|ANIP - Company Book Value|Accounting Value of Company MNKD (MannKind Corp)|Amphastar (AMPH) - Company Book Value|Company Net Assets Pacira Corp|SPRY (ARS Pharmaceuticals) - Book Capitalization|Book Capitalization theravance.com|Company Net Assets AQST (Aquestive Therapeutics, Inc.)|SCPH (scpharmaceuticals.com) - Accounting Value of Company|Company Book Value Tectonic Therapeutic TECX|Tonix Pharmaceuticals Holding (TNXP) - Total Stockholders' Equity|SXTC: Company Net Assets|Eupraxia Pharmaceuticals - Total Net Assets|BHST: Book Capitalization|Invizyne Technologies - Accounting Value of Company|ORMP (Oramed) - Book Capitalization|Total Stockholders' Equity Entera Bio Corp ENTX|Company Book Value MindWalk Holdings (HYFT)|ABVC (abvcpharma.com) - Accounting Value of Company|Company Book Value Cumberland Pharmaceuticals Inc. CPIX|Total Net Assets QNTM (Quantum BioPharma Ltd.)|FGEN: Company Net Assets|Total Stockholders' Equity Telomir Pharmaceuticals Corp|ranitherapeutics.com (RANI) - Company Book Value|Total Stockholders' Equity Synergy CHC (SNYR)|Company Book Value Rallybio Corp|Accounting Capitalization LEXX (Lexaria)|Book Capitalization PULM|ftzy.com.cn (PTHL) - Book Value of Business|Aptorum Group - Company Net Assets|Accounting Value of Company LYRA|Impact BioMedical Inc - Book Capitalization|TNFA: Company Book Value|YCBD: Book Capitalization|PRFX - Book Valuation of Business|Company Book Value Altamira Therapeutics Ltd|Total Stockholders' Equity lipella.com LIPO|Company Net Assets OPTN (OptiNose)|Total Net Assets PIRS|Book Capitalization PROC (Procaps Group SA)|Petros Pharma (PTPI) - Total Stockholders' Equity|Qilian International - Book Capitalization|acelyrin.com (SLRN) - Company Net Assets|TFFP: Book Capitalization